Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Tóm tắt
Từ khóa
Tài liệu tham khảo
National Center for Health Statistics, Health, United States, 2006, with chartbook on trends in the health of Americans
Jackson, 2004, The burden of community-acquired pneumonia in seniors: results of a population-based study, Clin Infect Dis, 39, 1642, 10.1086/425615
Feikin, 2000, Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997, Am J Public Health, 90, 223, 10.2105/AJPH.90.2.223
Flanders, 2004, Guidelines for community-acquired pneumonia: are they reflected in practice?, Treat Respir Med, 3, 67, 10.2165/00151829-200403020-00001
Niederman, 1993, Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association, Am Rev Respir Dis, 148, 1418, 10.1164/ajrccm/148.5.1418
Niederman, 2001, Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention, Am J Respir Crit Care Med, 163, 1730, 10.1164/ajrccm.163.7.at1010
Bartlett, 1998, Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America, Clin Infect Dis, 26, 811, 10.1086/513953
Bartlett, 2000, Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America, Clin Infect Dis, 31, 347, 10.1086/313954
Mandell, 2003, Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults, Clin Infect Dis, 37, 1405, 10.1086/380488
2005, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia, Am J Respir Crit Care Med, 171, 388, 10.1164/rccm.200405-644ST
Dean, 2000, Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia, Chest, 117, 393, 10.1378/chest.117.2.393
Attributes of ATS documents that guide clinical practice, 1997, Recommendations of the ATS Clinical Practice Committee, Am J Respir Crit Care Med, 156, 2015, 10.1164/ajrccm.156.6.ats9-97
Atkins, 2004, Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group, BMC Health Serv Res, 4, 38, 10.1186/1472-6963-4-38
Wunderink, 1998, Clinical practice guidelines for the management of pneumonia—do they work?, New Horiz, 6, 75
Cabana, 1999, Why don't physicians follow clinical practice guidelines?. A framework for improvement, JAMA, 282, 1458, 10.1001/jama.282.15.1458
Nathwani, 2001, Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?, Clin Infect Dis, 32, 728, 10.1086/319216
Menendez, 2002, Influence of deviation from guidelines on the outcome of community-acquired pneumonia, Chest, 122, 612, 10.1378/chest.122.2.612
Dean, 2001, Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia, Am J Med, 110, 451, 10.1016/S0002-9343(00)00744-0
Marrie, 2000, A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin, JAMA, 283, 749, 10.1001/jama.283.6.749
Capelastegui, 2004, Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study, Clin Infect Dis, 39, 955, 10.1086/423960
Benenson, 1999, Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality, Acad Emerg Med, 6, 1243, 10.1111/j.1553-2712.1999.tb00140.x
Suchyta, 2001, Effects of a practice guideline for community-acquired pneumonia in an outpatient setting, Am J Med, 110, 306, 10.1016/S0002-9343(00)00719-1
Mortensen, 2004, Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia, Am J Med, 117, 726, 10.1016/j.amjmed.2004.06.028
Atlas, 1998, Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial, Arch Intern Med, 158, 1350, 10.1001/archinte.158.12.1350
Coley, 1996, Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia, Arch Intern Med, 156, 1565, 10.1001/archinte.1996.00440130115012
Meehan, 2001, A statewide initiative to improve the care of hospitalized pneumonia patients: The Connecticut Pneumonia Pathway Project, Am J Med, 111, 203, 10.1016/S0002-9343(01)00803-8
Fine, 2003, Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial, Am J Med, 115, 343, 10.1016/S0002-9343(03)00395-4
Chu, 2003, Improving the quality of care for patients with pneumonia in very small hospitals, Arch Intern Med, 163, 326, 10.1001/archinte.163.3.326
Mundy, 2003, Early mobilization of patients hospitalized with community-acquired pneumonia, Chest, 124, 883, 10.1378/chest.124.3.883
Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103
Rhew, 1998, A prospective, multicenter study of a pneumonia practice guideline, Chest, 114, 115, 10.1378/chest.114.1.115
Halm, 2004, Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care, Chest, 126, 100, 10.1378/chest.126.1.100
Niederman, 1998, The cost of treating community-acquired pneumonia, Clin Ther, 20, 820, 10.1016/S0149-2918(98)80144-6
Carratala, 2005, Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients, Ann Intern Med, 142, 165, 10.7326/0003-4819-142-3-200502010-00006
Alikhan, 2004, Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study, Arch Intern Med, 164, 963, 10.1001/archinte.164.9.963
McMahon, 1989, Variation in hospital admissions among small areas: a comparison of Maine and Michigan, Med Care, 27, 623, 10.1097/00005650-198906000-00005
Fine, 1997, The hospital admission decision for patients with community-acquired pneumonia: results from the pneumonia Patient Outcomes Research Team cohort study, Arch Intern Med, 157, 36, 10.1001/archinte.1997.00440220040006
British Thoracic Society Research Committee, 1987, Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors, and outcome, Q J Med, 62, 195, 10.1093/oxfordjournals.qjmed.a068093
Black, 1991, Predicting the need for hospitalization of ambulatory patients with pneumonia, J Gen Intern Med, 6, 394, 10.1007/BF02598159
Daley, 1988, Predicting hospital-associated mortality for Medicare patients: a method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure, JAMA, 260, 3617, 10.1001/jama.1988.03410240087037
Fine, 1997, A prediction rule to identify low-risk patients with community-acquired pneumonia, N Engl J Med, 336, 243, 10.1056/NEJM199701233360402
Fine, 1990, Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study, Am J Med, 89, 713, 10.1016/0002-9343(90)90211-U
Fine, 1993, Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database, Am J Med, 94, 153, 10.1016/0002-9343(93)90177-Q
Lim, 2003, Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study, Thorax, 58, 377, 10.1136/thorax.58.5.377
Marrie, 1989, Community-acquired pneumonia requiring hospitalization: 5-year prospective study, Rev Infect Dis, 11, 586, 10.1093/clinids/11.4.586
Ortqvist, 1990, Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization, Eur Respir J, 3, 1105, 10.1183/09031936.93.03101105
Porath, 1996, Appropriateness of hospitalization of patients with community-acquired pneumonia, Ann Emerg Med, 27, 176, 10.1016/S0196-0644(96)70320-7
Auble, 1998, Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia, Infect Dis Clin North Am, 12, 741, 10.1016/S0891-5520(05)70208-7
Yealy, 2005, Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial, Ann Intern Med, 143, 881, 10.7326/0003-4819-143-12-200512200-00006
Neill, 1996, Community acquired pneumonia: aetiology and usefulness of severity criteria on admission, Thorax, 51, 1010, 10.1136/thx.51.10.1010
Dean, 1999, Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia, Clin Chest Med, 20, 521, 10.1016/S0272-5231(05)70233-1
Woodhead, 2003, Assessment of illness severity in community acquired pneumonia: a useful new prediction tool?, Thorax, 58, 371, 10.1136/thorax.58.5.371
Capelastegui, 2006, Validation of a predictive rule for the management of community-acquired pneumonia, Eur Respir J, 27, 151, 10.1183/09031936.06.00062505
Espana, 2003, A prediction rule to identify allocation of inpatient care in community-acquired pneumonia, Eur Respir J, 21, 695, 10.1183/09031936.03.00057302
Aujesky, 2005, Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia, Am J Med, 118, 384, 10.1016/j.amjmed.2005.01.006
Dean, 2000, Implementation of admission decision support for community-acquired pneumonia, Chest, 117, 1368, 10.1378/chest.117.5.1368
Aronsky, 2001, How should we make the admission decision in community-acquired pneumonia?, Med Clin North Am, 85, 1397, 10.1016/S0025-7125(05)70387-4
Wright, 2004, Improving the implementation of community-acquired pneumonia guidelines, Intern Med J, 34, 507, 10.1111/j.1445-5994.2004.00638.x
Arnold, 2003, Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment, Chest, 124, 121, 10.1378/chest.124.1.121
Goss, 2003, Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital, Chest, 124, 2148, 10.1378/chest.124.6.2148
Riley, 2004, Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia, Crit Care Med, 32, 2398, 10.1097/01.CCM.0000147443.38234.D2
Angus, 2002, Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria, Am J Respir Crit Care Med, 166, 717, 10.1164/rccm.2102084
Halm, 2000, Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors, Arch Intern Med, 160, 98, 10.1001/archinte.160.1.98
Marrie, 2005, Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU, Chest, 127, 1260
Metlay, 2003, Testing strategies in the initial management of patients with community-acquired pneumonia, Ann Intern Med, 138, 109, 10.7326/0003-4819-138-2-200301210-00012
Marras, 2000, Applying a prediction rule to identify low-risk patients with community-acquired pneumonia, Chest, 118, 1339, 10.1378/chest.118.5.1339
Roson, 2001, Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria, Clin Infect Dis, 33, 158, 10.1086/321808
El Solh, 2001, Etiology of severe pneumonia in the very elderly, Am J Respir Crit Care Med, 163, 645, 10.1164/ajrccm.163.3.2005075
Luna, 2000, Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina, Chest, 118, 1344, 10.1378/chest.118.5.1344
Garcia-Ordonez, 2001, Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia, Eur J Clin Microbiol Infect Dis, 20, 14, 10.1007/s100960000413
Meehan, 2000, Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia, Chest, 117, 1378, 10.1378/chest.117.5.1378
Lim, 2001, Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines, Thorax, 56, 296, 10.1136/thorax.56.4.296
Leroy, 1995, A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit, Intensive Care Med, 21, 24, 10.1007/BF02425150
Ewig, 2004, Validation of predictive rules and indices of severity for community acquired pneumonia, Thorax, 59, 421, 10.1136/thx.2003.008110
Sanyal, 1999, Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia, Am J Respir Crit Care Med, 160, 346, 10.1164/ajrccm.160.1.9806048
Marik, 2000, The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators, J Crit Care, 15, 85, 10.1053/jcrc.2000.16460
Ruiz, 1999, Severe community-acquired pneumonia, Am J Respir Crit Care Med, 160, 923, 10.1164/ajrccm.160.3.9901107
Paganin, 2004, Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor, Eur Respir J, 24, 779, 10.1183/09031936.04.00119503
Kollef, 1999, Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients, Chest, 115, 462, 10.1378/chest.115.2.462
Roson, 2004, Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia, Arch Intern Med, 164, 502, 10.1001/archinte.164.5.502
Ewig, 1998, Severe community-acquired pneumonia: assessment of severity criteria, Am J Respir Crit Care Med, 158, 1102, 10.1164/ajrccm.158.4.9803114
Mortensen, 2002, Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study, Arch Intern Med, 162, 1059, 10.1001/archinte.162.9.1059
Menendez, 2004, Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome, Thorax, 59, 960, 10.1136/thx.2003.017756
Perlino, 1985, Alcoholism, leukopenia, and pneumococcal sepsis, Am Rev Respir Dis, 132, 757
Watanakunakorn, 1997, Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992–1996: a detailed analysis of 108 cases, Arch Intern Med, 157, 1965, 10.1001/archinte.1997.00440380069007
Leroy, 1996, Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score, Intensive Care Medicine, 22, 1307, 10.1007/BF01709543
Feldman, 1990, Klebsielle pneumoniae bacteremia at an urban general hospital, J Infect, 20, 21, 10.1016/S0163-4453(90)92258-M
Chen, 2001, Severe community-acquired pneumonia due to Acinetobacter baumannii, Chest, 120, 1072, 10.1378/chest.120.4.1072
Querol-Ribelles, 2004, Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia, Chest, 126, 1087, 10.1378/chest.126.4.1087
Kuikka, 1992, Pneumococcal bacteraemia during a recent decade, J Infect, 24, 157, 10.1016/0163-4453(92)92850-I
Laterre, 2005, Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study, Crit Care Med, 33, 952, 10.1097/01.CCM.0000162381.24074.D7
Marik, 2000, Hypothermia and cytokines in septic shock. Norasept II Study Investigators: North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock, Intensive Care Med, 26, 716, 10.1007/s001340051237
Fernández-Solá, 1995, High alcohol intake as a risk and prognostic factor for community-acquired pneumonia, Arch Intern Med, 155, 1649, 10.1001/archinte.1995.00430150137014
Metersky, 2004, Predicting bacteremia in patients with community-acquired pneumonia, Am J Respir Crit Care Med, 169, 342, 10.1164/rccm.200309-1248OC
Wipf, 1999, Diagnosing pneumonia by physical examination: relevant or relic?, Arch Intern Med, 159, 1082, 10.1001/archinte.159.10.1082
Mower, 1995, Effect of routine emergency department triage pulse oximetry screening on medical management, Chest, 108, 1297, 10.1378/chest.108.5.1297
Levin, 2001, Arterial blood gas and pulse oximetry in initial management of patients with community-acquired pneumonia, J Gen Intern Med, 16, 590, 10.1046/j.1525-1497.2001.016009590.x
Syrjala, 1998, High-resolution computed tomography for the diagnosis of community-acquired pneumonia, Clin Infect Dis, 27, 358, 10.1086/514675
Valdivia, 2006, Coccidioidomycosis as a common cause of community-acquired pneumonia, Emerg Infect Dis, 12, 958, 10.3201/eid1206.060028
Arancibia, 2000, Antimicrobial treatment failures in patients with community-acquired pneumonia, Am J Respir Crit Care Med, 162, 154, 10.1164/ajrccm.162.1.9907023
King, 2003, Recurrent invasive pneumococcal disease: a population-based assessment, Clin Infect Dis, 37, 1029, 10.1086/377736
US Department of Health and Human Services, Sepsis and CAP: partnerships for diagnostics development, RFA no. RFA-AI-04-043
Campbell, 2003, The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study, Chest, 123, 1142, 10.1378/chest.123.4.1142
Waterer, 2001, The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures, Respir Med, 95, 78, 10.1053/rmed.2000.0977
Malcolm, 2003, Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting, Arch Intern Med, 163, 797, 10.1001/archinte.163.7.797
Falsey, 2005, Respiratory syncytial virus infection in elderly and high-risk adults, N Engl J Med, 352, 1749, 10.1056/NEJMoa043951
van der Eerden, 2005, Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study, Thorax, 60, 672, 10.1136/thx.2004.030411
Houck, 2004, Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia, Arch Intern Med, 164, 637, 10.1001/archinte.164.6.637
Fine, 1996, Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis, JAMA, 275, 134, 10.1001/jama.1996.03530260048030
Metersky, 2003, Is the lateral decubitus radiograph necessary for the management of a parapneumonic pleural effusion?, Chest, 124, 1129, 10.1378/chest.124.3.1129
Yu, 2003, An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome, Clin Infect Dis, 37, 230, 10.1086/377534
Ruiz, 1999, Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity, Am J Respir Crit Care Med, 160, 397, 10.1164/ajrccm.160.2.9808045
Confalonieri, 1999, Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation, Am J Respir Crit Care Med, 160, 1585, 10.1164/ajrccm.160.5.9903015
Barrett-Connor, 1971, The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia, Am Rev Respir Dis, 103, 845
Lentino, 1987, Nonvalue of sputum culture in the management of lower respiratory tract infections, J Clin Microbiol, 25, 758, 10.1128/JCM.25.5.758-762.1987
Musher, 2004, Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia, Clin Infect Dis, 39, 165, 10.1086/421497
Gleckman, 1988, Sputum gram stain assessment in community-acquired bacteremic pneumonia, J Clin Microbiol, 26, 846, 10.1128/JCM.26.5.846-849.1988
Reed, 1996, Sputum gram's stain in community-acquired pneumococcal pneumonia: a meta-analysis, West J Med, 165, 197
Garcia-Vazquez, 2004, Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system, Arch Intern Med, 164, 1807, 10.1001/archinte.164.16.1807
Bartlett, 1977, Diagnostic accuracy of transtracheal aspiration bacteriologic studies, Am Rev Respir Dis, 115, 777
Bartlett, 1978, Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates, Am Rev Respir Dis, 117, 1019
Jimenez, 1993, Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia: comparison between bronchoalveolar lavage and telescoping plugged catheter cultures, Chest, 103, 1023, 10.1378/chest.103.4.1023
Zalacain, 1995, Influence of three factors on the diagnostic effectiveness of transthoracic needle aspiration in pneumonia, Chest, 107, 96, 10.1378/chest.107.1.96
Scott, 1999, The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia, Chest, 116, 1716, 10.1378/chest.116.6.1716
Ishida, 2001, Efficacy of transthoracic needle aspiration in community-acquired pneumonia, Intern Med, 40, 873, 10.2169/internalmedicine.40.873
Bartlett, 1987, Diagnosis of bacterial infections of the lung, Clin Chest Med, 8, 119, 10.1016/S0272-5231(21)00471-8
Heineman, 1977, Misinformation from sputum cultures without microscopic examination, J Clin Microbiol, 6, 518, 10.1128/jcm.6.5.518-527.1977
Wimberley, 1979, A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture, Am Rev Respir Dis, 119, 337
Fields, 2002, Legionella and Legionnaires' disease: 25 years of investigation, Clin Microbiol Rev, 15, 506, 10.1128/CMR.15.3.506-526.2002
Arancibia, 2002, Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis, Arch Intern Med, 162, 1849, 10.1001/archinte.162.16.1849
Fraser, 1977, Legionnaires' disease: description of an epidemic of pneumonia, N Engl J Med, 297, 1189, 10.1056/NEJM197712012972201
Cowgill, 2005, Recurrence of legionnaires disease at a hotel in the United States Virgin Islands over a 20-year period, Clin Infect Dis, 40, 1205, 10.1086/428844
Jernigan, 1996, Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa, Lancet, 347, 494, 10.1016/S0140-6736(96)91137-X
den Boer, 2002, A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999, Emerg Infect Dis, 8, 37, 10.3201/eid0801.010176
Garcia-Fulgueiras, 2003, Legionnaires' disease outbreak in Murcia, Spain, Emerg Infect Dis, 9, 915, 10.3201/eid0908.030337
Benkel, 2000, Outbreak of Legionnaires' disease associated with a display whirlpool spa, Int J Epidemiol, 29, 1092, 10.1093/ije/29.6.1092
Helbig, 2001, Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA, J Med Microbiol, 50, 509, 10.1099/0022-1317-50-6-509
Yzerman, 2002, Sensitivity of three urinary antigen tests associated with clinical severity in a large outbreak of Legionnaires' disease in The Netherlands, J Clin Microbiol, 40, 3232, 10.1128/JCM.40.9.3232-3236.2002
Roson, 2004, Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia, Clin Infect Dis, 38, 222, 10.1086/380639
Ishida, 2004, A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology, J Infect Chemother, 10, 359, 10.1007/s10156-004-0351-1
Stralin, 2004, Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia, J Clin Microbiol, 42, 3620, 10.1128/JCM.42.8.3620-3625.2004
Marcos, 2003, Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults, Eur Respir J, 21, 209, 10.1183/09031936.03.00058802
Rodriguez, 2001, An emergency department-based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia, Ann Emerg Med, 38, 357, 10.1067/mem.2001.118014
van der Eerden, 2005, Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia, Eur J Clin Microbiol Infect Dis, 24, 241, 10.1007/s10096-005-1316-8
Dominguez, 2001, Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples, Chest, 119, 243, 10.1378/chest.119.1.243
Smith, 2003, Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation, J Clin Microbiol, 41, 2810, 10.1128/JCM.41.7.2810-2813.2003
Benson, 2000, Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires' disease due to multiple serogroups and species of Legionella, J Clin Microbiol, 38, 2763, 10.1128/JCM.38.7.2763-2765.2000
Gutierrez, 2003, Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain, Clin Infect Dis, 36, 286, 10.1086/345852
Murdoch, 2001, Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia, J Clin Microbiol, 39, 3495, 10.1128/JCM.39.10.3495-3498.2001
Navarro, 2004, Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection, J Clin Microbiol, 42, 4853, 10.1128/JCM.42.10.4853-4855.2004
Murdoch, 2003, The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD, Clin Infect Dis, 37, 153, 10.1086/375610
Waterer, 2001, Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint, Am J Med, 110, 41, 10.1016/S0002-9343(00)00624-0
Bates, 1992, Microbial etiology of acute pneumonia in hospitalized patients, Chest, 101, 1005, 10.1378/chest.101.4.1005
Plouffe, 2003, Azithromycin in the treatment of Legionella pneumonia requiring hospitalization, Clin Infect Dis, 37, 1475, 10.1086/379329
Kaiser, 1999, Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection, J Clin Virol, 14, 191, 10.1016/S1386-6532(99)00058-X
Bellei, 2003, Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment, J Virol Methods, 109, 85, 10.1016/S0166-0934(03)00050-8
Landry, 2004, Comparison of Binax NOW and Directigen for rapid detection of influenza A and B, J Clin Virol, 31, 113, 10.1016/j.jcv.2004.04.005
Monto, 2000, Clinical signs and symptoms predicting influenza infection, Arch Intern Med, 160, 3243, 10.1001/archinte.160.21.3243
Shetty, 2003, Comparison of conventional viral cultures with direct fluorescent antibody stains for diagnosis of community-acquired respiratory virus infections in hospitalized children, Pediatr Infect Dis J, 22, 789, 10.1097/01.inf.0000083823.43526.97
Chan, 2002, Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections, J Clin Microbiol, 40, 1675, 10.1128/JCM.40.5.1675-1680.2002
Casiano-Colon, 2003, Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults, J Clin Virol, 28, 169, 10.1016/S1386-6532(03)00002-7
Littman, 2004, Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers, Clin Diagn Lab Immunol, 11, 615, 10.1128/CDLI.11.3.615-617.2004
Bartlett, 2004, Diagnostic test for etiologic agents of community-acquired pneumonia, Infect Dis Clin North Am, 18, 809, 10.1016/j.idc.2004.08.002
Dowell, 2001, Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), Clin Infect Dis, 33, 492, 10.1086/322632
Templeton, 2005, Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction, Clin Infect Dis, 41, 345, 10.1086/431588
Mundy, 1995, Community-acquired pneumonia: impact of immune status, Am J Respir Crit Care Med, 152, 1309, 10.1164/ajrccm.152.4.7551387
Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5
Revised, 2003, surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases—United States and worldwide, December 2003, MMWR Morb Mortal Wkly Rep, 52, 1202
Fang, 1990, New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases, Medicine (Baltimore), 69, 307, 10.1097/00005792-199009000-00004
Farr, 1989, Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee, Thorax, 44, 1031, 10.1136/thx.44.12.1031
Marrie, 1996, Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course, Am J Med, 101, 508, 10.1016/S0002-9343(96)00255-0
Lieberman, 1996, Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients, Thorax, 51, 179, 10.1136/thx.51.2.179
de Roux, 2004, Viral community-acquired pneumonia in nonimmunocompromised adults, Chest, 125, 1343, 10.1378/chest.125.4.1343
Falguera, 2001, Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity, Arch Intern Med, 161, 1866, 10.1001/archinte.161.15.1866
Sirvent, 1997, Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma, Am J Respir Crit Care Med, 155, 1729, 10.1164/ajrccm.155.5.9154884
Waterer, 2003, Decreasing β-lactam resistance in Pneumococci from the Memphis region: analysis of 2,152 isolates from 1996 to 2001, Chest, 124, 519, 10.1378/chest.124.2.519
Chen, 1999, Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network, N Engl J Med, 341, 233, 10.1056/NEJM199907223410403
Hyde, 2001, Macrolide resistance among invasive Streptococcus pneumoniae isolates, JAMA, 286, 1857, 10.1001/jama.286.15.1857
Perez-Trallero, 2005, Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain, Antimicrob Agents Chemother, 49, 1965, 10.1128/AAC.49.5.1965-1972.2005
Metlay, 2004, Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia, Infect Dis Clin North Am, 18, 777, 10.1016/j.idc.2004.07.003
Bauer, 2001, Streptococcus pneumoniae in community-acquired pneumonia: how important is drug resistance?, Med Clin North Am, 85, 1367, 10.1016/S0025-7125(05)70385-0
Heffelfinger, 2000, Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group, Arch Intern Med, 160, 1399, 10.1001/archinte.160.10.1399
Pallares, 2002, The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections, Am J Med, 113, 120, 10.1016/S0002-9343(02)01162-2
Musher, 2002, Emergence of macrolide resistance during treatment of pneumococcal pneumonia, N Engl J Med, 346, 630, 10.1056/NEJM200202213460820
Kelley, 2000, Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin, Clin Infect Dis, 31, 1008, 10.1086/318157
Lonks, 2002, Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae, Clin Infect Dis, 35, 556, 10.1086/341978
Davidson, 2002, Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia, N Engl J Med, 346, 747, 10.1056/NEJMoa012122
Ho, 2001, Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000, J Antimicrob Chemother, 48, 659, 10.1093/jac/48.5.659
Clavo-Sanchez, 1997, Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study, Clin Infect Dis, 24, 1052, 10.1086/513628
Vanderkooi, 2005, Predicting antimicrobial resistance in invasive pneumococcal infections, Clin Infect Dis, 40, 1288, 10.1086/429242
Ho, 2001, Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study, Clin Infect Dis, 32, 701, 10.1086/319222
Ruhe, 2003, Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance, Clin Infect Dis, 36, 1132, 10.1086/374556
Anderson, 2003, Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia, Clin Infect Dis, 37, 376, 10.1086/376642
Urban, 2001, Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy, J Infect Dis, 184, 794, 10.1086/323086
Gorak, 1999, Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors, Clin Infect Dis, 29, 797, 10.1086/520437
Dufour, 2002, Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin, Clin Infect Dis, 35, 819, 10.1086/342576
Mongkolrattanothai, 2003, Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates, Clin Infect Dis, 37, 1050, 10.1086/378277
Deresinski, 2005, Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey, Clin Infect Dis, 40, 562, 10.1086/427701
Fridkin, 2005, Methicillin-resistant Staphylococcus aureus disease in three communities, N Engl J Med, 352, 1436, 10.1056/NEJMoa043252
Micek, 2005, Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production, Chest, 128, 2732, 10.1378/chest.128.4.2732
Bochud, 2001, Community-acquired pneumonia: a prospective outpatient study, Medicine (Baltimore), 80, 75, 10.1097/00005792-200103000-00001
Shefet, 2005, Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials, Arch Intern Med, 165, 1992, 10.1001/archinte.165.17.1992
Mills, 2005, Effectiveness of β-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis, BMJ, 330, 456, 10.1136/bmj.38334.591586.82
McCracken, 1986, Current status of antibiotic treatment for Mycoplasma pneumoniae infections, Pediatr Infect Dis, 5, 167, 10.1097/00006454-198601000-00054
Lautenbach, 2003, Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use, Arch Intern Med, 163, 601, 10.1001/archinte.163.5.601
Pichichero, 2005, A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients, Pediatrics, 115, 1048, 10.1542/peds.2004-1276
Tellier, 2004, Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia, J Antimicrob Chemother, 54, 515, 10.1093/jac/dkh356
Mathers, 2004, Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults, Clin Ther, 26, 48, 10.1016/S0149-2918(04)90005-7
Pullman, 2003, Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults, Int J Clin Pract, 57, 377, 10.1111/j.1742-1241.2003.tb10511.x
Hagberg, 2003, Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis, Respir Med, 97, 625, 10.1053/rmed.2003.1492
Clay, 2006, Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review, Ann Intern Med, 144, 415, 10.7326/0003-4819-144-6-200503210-00121
Gleason, 1999, Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia, Arch Intern Med, 159, 2562, 10.1001/archinte.159.21.2562
Houck, 2001, Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997, Chest, 119, 1420, 10.1378/chest.119.5.1420
Dudas, 2000, Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals, Ann Pharmacother, 34, 446, 10.1345/aph.19174
Brown, 2003, Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database, Chest, 123, 1503, 10.1378/chest.123.5.1503
Musher, 2001, A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics, Arch Intern Med, 161, 2538, 10.1001/archinte.161.21.2538
Vetter, 2002, A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia, Clin Ther, 24, 1770, 10.1016/S0149-2918(02)80078-9
Ortiz-Ruiz, 2004, Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies, J Antimicrob Chemother, 53, ii59
Ailani, 1999, Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia, Arch Intern Med, 159, 266, 10.1001/archinte.159.3.266
Ragnar, 1997, Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group, J Antimicrob Chemother, 39, 499, 10.1093/jac/39.4.499
Vergis, 2000, Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial, Arch Intern Med, 160, 1294, 10.1001/archinte.160.9.1294
Plouffe, 2000, Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group, Antimicrob Agents Chemother, 44, 1796, 10.1128/AAC.44.7.1796-1802.2000
Feldman, 2003, Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 3 1/2-year experience from a veterans affairs hospital, Arch Intern Med, 163, 1718, 10.1001/archinte.163.14.1718
Marras, 2004, Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis, Am J Med, 116, 385, 10.1016/j.amjmed.2003.11.013
Leroy, 2005, Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors, Chest, 128, 172, 10.1378/chest.128.1.172
Torres, 1991, Severe community-acquired pneumonia: epidemiology and prognostic factors, Am Rev Respir Dis, 144, 312, 10.1164/ajrccm/144.2.312
Mufson, 1999, Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978–1997, Am J Med, 107, 34, 10.1016/S0002-9343(99)00098-4
Baddour, 2004, Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia, Am J Respir Crit Care Med, 170, 440, 10.1164/rccm.200311-1578OC
Waterer, 2001, Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia, Arch Intern Med, 161, 1837, 10.1001/archinte.161.15.1837
Martinez, 2003, Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia, Clin Infect Dis, 36, 389, 10.1086/367541
Weiss, 2004, Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults, Can Respir J, 11, 589, 10.1155/2004/461392
Sopena, 2005, Multicenter study of hospital-acquired pneumonia in non-ICU patients, Chest, 127, 213, 10.1378/chest.127.1.213
Venezia, 2001, Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure, J Antimicrob Chemother, 48, 375, 10.1093/jac/48.3.375
Gonzalez, 1999, Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms, Clin Infect Dis, 29, 1171, 10.1086/313440
Markowitz, 1992, Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection, Ann Intern Med, 117, 390, 10.7326/0003-4819-117-5-390
San Pedro, 2002, Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia, Scand J Infect Dis, 34, 720, 10.1080/0036554021000026933
Wunderink, 2003, Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia, Chest, 124, 1789, 10.1016/S0012-3692(15)33412-7
Bernardo, 2004, Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression, Antimicrob Agents Chemother, 48, 546, 10.1128/AAC.48.2.546-555.2004
American Thoracic Society Centers for Disease Control and Prevention Infectious Diseases Society of America, 2005, American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States, Am J Respir Crit Care Med, 172, 1169, 10.1164/rccm.2508001
Amsden, 2005, Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?, J Antimicrob Chemother, 55, 10, 10.1093/jac/dkh519
Tamaoki, 2004, Clinical implications of the immunomodulatory effects of macrolides, Am J Med, 117, 5
Nicholson, 2000, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group, Lancet, 355, 1845, 10.1016/S0140-6736(00)02288-1
Monto, 1999, Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections, J Infect Dis, 180, 254, 10.1086/314904
Kaiser, 2003, Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations, Arch Intern Med, 163, 1667, 10.1001/archinte.163.14.1667
Jefferson, 2006, Antivirals for influenza in healthy adults: systematic review, Lancet, 367, 303, 10.1016/S0140-6736(06)67970-1
Kaiser, 1999, Hospitalizing influenza in adults, Curr Clin Top Infect Dis, 19, 112
Gubareva, 2000, Influenza virus neuraminidase inhibitors, Lancet, 355, 827, 10.1016/S0140-6736(99)11433-8
2006, High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents—United States, 2005–06 influenza season, MMWR Morb Mortal Wkly Rep, 55, 44
Bright, 2006, Adamantane resistance among influenza A viruses isolated early during the 2005–2006 influenza season in the United States, JAMA, 295, 891, 10.1001/jama.295.8.joc60020
Kaiser, 2000, Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults, Arch Intern Med, 160, 3234, 10.1001/archinte.160.21.3234
Treanor, 2000, Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group, JAMA, 283, 1016, 10.1001/jama.283.8.1016
Hayden, 1999, Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment, JAMA, 282, 1240, 10.1001/jama.282.13.1240
Haake, 1990, Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review, Rev Infect Dis, 12, 788, 10.1093/clinids/12.5.788
Hien, 2004, Avian influenza—a challenge to global health care structures, N Engl J Med, 351, 2363, 10.1056/NEJMp048267
Chotpitayasunondh, 2005, Human disease from influenza A (H5N1), Thailand, 2004, Emerg Infect Dis, 11, 201, 10.3201/eid1102.041061
World Health Organization, Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses: interim biosafety assessment
Beigel, 2005, Avian influenza A (H5N1) infection in humans, N Engl J Med, 353, 1374, 10.1056/NEJMra052211
de Jong, 2005, Oseltamivir resistance during treatment of influenza A (H5N1) infection, N Engl J Med, 353, 2667, 10.1056/NEJMoa054512
Meehan, 1997, Quality of care, process, and outcomes in elderly patients with pneumonia, JAMA, 278, 2080, 10.1001/jama.1997.03550230056037
Silber, 2003, Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia, Chest, 124, 1798, 10.1378/chest.124.5.1798
Battleman, 2002, Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization, Arch Intern Med, 162, 682, 10.1001/archinte.162.6.682
Ziss, 2003, Community-acquired pneumonia: compliance with centers for Medicare and Medicaid services, national guidelines, and factors associated with outcome, South Med J, 96, 949, 10.1097/01.SMJ.0000051147.88941.FB
Ramirez, 1995, Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia, Arch Intern Med, 155, 1273, 10.1001/archinte.1995.00430120050006
Castro-Guardiola, 2001, Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial, Am J Med, 111, 367, 10.1016/S0002-9343(01)00868-3
Ramirez, 2001, Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia, Arch Intern Med, 161, 848, 10.1001/archinte.161.6.848
Ramirez, 1999, Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia, Arch Intern Med, 159, 2449, 10.1001/archinte.159.20.2449
Halm, 2001, What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia?, J Gen Intern Med, 16, 599, 10.1046/j.1525-1497.2001.016009599.x
Halm, 2002, Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia, Arch Intern Med, 162, 1278, 10.1001/archinte.162.11.1278
Halm, 1998, Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines, JAMA, 279, 1452, 10.1001/jama.279.18.1452
Zervos, 2004, Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia, Treat Respir Med, 3, 329, 10.2165/00151829-200403050-00006
Dunbar, 2003, High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm, Clin Infect Dis, 37, 752, 10.1086/377539
Rizzato, 1995, Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia, Eur Respir J, 8, 398, 10.1183/09031936.95.08030398
Schonwald, 1991, Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia, Eur J Clin Microbiol Infect Dis, 10, 877, 10.1007/BF01975847
Chastre, 2003, Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial, JAMA, 290, 2588, 10.1001/jama.290.19.2588
Bernard, 2001, Efficacy and safety of recombinant human activated protein C for severe sepsis, N Engl J Med, 344, 699, 10.1056/NEJM200103083441001
Ely, 2003, Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis, Crit Care Med, 31, 12, 10.1097/00003246-200301000-00002
Opal, 2003, Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated), Clin Infect Dis, 37, 50, 10.1086/375593
Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862
Torres, 1999, Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study, Eur Respir J, 14, 218, 10.1034/j.1399-3003.1999.14a37.x
Confalonieri, 2005, Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study, Am J Respir Crit Care Med, 171, 242, 10.1164/rccm.200406-808OC
Marik, 1993, Hydrocortisone and tumour necrosis factor in severe community acquired pneumonia, Chest, 104, 389, 10.1378/chest.104.2.389
Van den Berghe, 2001, Intensive insulin therapy in the critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300
Brochard, 1995, Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, 333, 817, 10.1056/NEJM199509283331301
Ferrer, 2003, Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial, Am J Respir Crit Care Med, 168, 1438, 10.1164/rccm.200301-072OC
Antonelli, 2001, Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study, Intensive Care Med, 27, 1718, 10.1007/s00134-001-1114-4
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury the acute respiratory distress syndrome, 2000, The Acute Respiratory Distress Syndrome Network, N Engl J Med, 342, 1301
Eisner, 2001, Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome, Am J Respir Crit Care Med, 164, 231, 10.1164/ajrccm.164.2.2011093
Dellinger, 2004, Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock, Crit Care Med, 32, 858, 10.1097/01.CCM.0000117317.18092.E4
Menéndez, 2004, Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients, Clin Infect Dis, 39, 1783, 10.1086/426028
Almirall, 2000, Epidemiology of community-acquired pneumonia in adults: a population-based study, Eur Respir J, 15, 757, 10.1034/j.1399-3003.2000.15d21.x
Celis, 1988, Nosocomial pneumonia: a multivariate analysis of risk and prognosis, Chest, 93, 318, 10.1378/chest.93.2.318
Daifuku, 1996, Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia, Respir Med, 90, 587, 10.1016/S0954-6111(96)90016-5
Mittl, 1994, Radiographic resolution of community-acquired pneumonia, Am J Respir Crit Care Med, 149, 630, 10.1164/ajrccm.149.3.8118630
El Solh, 2003, Microbiology of severe aspiration pneumonia in institutionalized elderly, Am J Respir Crit Care Med, 167, 1650, 10.1164/rccm.200212-1543OC
Ortqvist, 1990, Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia, Chest, 97, 576, 10.1378/chest.97.3.576
Fagon, 2000, Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial, Ann Intern Med, 132, 621, 10.7326/0003-4819-132-8-200004180-00004
Ruiz, 2000, Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome, Am J Respir Crit Care Med, 162, 119, 10.1164/ajrccm.162.1.9907090
Sabria, 2005, Fluoroquinolones vs macrolides in the treatment of Legionnaires disease, Chest, 128, 1401, 10.1378/chest.128.3.1401
Harper, 2005, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 54, 1
Bridges, 2003, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 52, 1
Butler, 1993, Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations, JAMA, 270, 1826, 10.1001/jama.1993.03510150060030
Sims, 1988, The clinical effectiveness of pneumococcal vaccine in the elderly, Ann Intern Med, 108, 653, 10.7326/0003-4819-108-5-653
Shapiro, 1991, The protective efficacy of polyvalent pneumococcal polysaccharide vaccine, N Engl J Med, 325, 1453, 10.1056/NEJM199111213252101
Farr, 1995, Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study, Arch Intern Med, 155, 2336, 10.1001/archinte.1995.00430210086013
Jackson, 2003, Effectiveness of pneumococcal polysaccharide vaccine in older adults, N Engl J Med, 348, 1747, 10.1056/NEJMoa022678
Sisk, 1997, Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people, JAMA, 278, 1333, 10.1001/jama.1997.03550160053038
Sisk, 2003, Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race, Ann Intern Med, 138, 960, 10.7326/0003-4819-138-12-200306170-00007
Jackson, 1999, Safety of revaccination with pneumococcal polysaccharide vaccine, JAMA, 281, 243, 10.1001/jama.281.3.243
Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823
Flannery, 2004, Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections, JAMA, 291, 2197, 10.1001/jama.291.18.2197
Lexau, 2005, Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine, JAMA, 294, 2043, 10.1001/jama.294.16.2043
Gross, 1995, The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature, Ann Intern Med, 123, 518, 10.7326/0003-4819-123-7-199510010-00008
Jefferson, 2005, Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review, Lancet, 366, 1165, 10.1016/S0140-6736(05)67339-4
Nichol, 2003, Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly, N Engl J Med, 348, 1322, 10.1056/NEJMoa025028
Carman, 2000, Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial, Lancet, 355, 93, 10.1016/S0140-6736(99)05190-9
Potter, 1997, Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients, J Infect Dis, 175, 1, 10.1093/infdis/175.1.1
2003, Public health and aging: influenza vaccination coverage among adults aged ⩾50 years and pneumococcal vaccination coverage among adults aged ⩾65 years—United States, 2002, MMWR Morb Mortal Wkly Rep, 52, 987
2004, Influenza and pneumococcal vaccination coverage among persons aged ⩾65 years and persons aged 18–64 years with diabetes or asthma—United States, 2003, MMWR Morb Mortal Wkly Rep, 53, 1007
From the Centers for Disease Control Prevention, 2003, Facilitating influenza and pneumococcal vaccination through standing orders programs, JAMA, 289, 1238, 10.1001/jama.289.10.1238
Monto, 2002, Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households, J Infect Dis, 186, 1582, 10.1086/345722
Hayden, 2004, Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis, J Infect Dis, 189, 440, 10.1086/381128
Ward, 2005, Efficacy of an acellular pertussis vaccine among adolescents and adults, N Engl J Med, 353, 1555, 10.1056/NEJMoa050824
Nuorti, 2000, Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team, N Engl J Med, 342, 681, 10.1056/NEJM200003093421002
Marston, 1994, Surveillance for Legionnaires' disease: risk factors for morbidity and mortality, Arch Intern Med, 154, 2417, 10.1001/archinte.1994.00420210049006
McDonald, 2004, SARS in healthcare facilities, Toronto and Taiwan, Emerg Infect Dis, 10, 777, 10.3201/eid1005.030791
Nuorti, 1998, An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents, N Engl J Med, 338, 1861, 10.1056/NEJM199806253382601
Hyde, 2001, Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia, J Infect Dis, 183, 907, 10.1086/319258
Centers for Disease Control and Prevention (CDC), Respiratory hygiene/cough etiquette in health-care settings
2004, Experiences with influenza-like illness and attitudes regarding influenza prevention—United States, 2003–04 influenza season, MMWR Morb Mortal Wkly Rep, 53, 1156